David W Vredevoogd

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Venues

The EMBO journal

Nature communications

Nature medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

Netherlands Cancer Institute

Universiteit van Amsterdam (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Netherlands Cancer Institute Aug 31 2015

Netherlands

PhD Student :: Molecular Oncology and Immunology

Education History

Universiteit van Amsterdam Sep 01 2013 - Aug 31 2015

Netherlands

MSC :: Biomedical Sciences

Publications

Chun-Pu Lin, Joleen J H Traets, David W Vredevoogd, Nils L Visser, Daniel S Peeper
TSC2 regulates tumor susceptibility to TRAIL-mediated T-cell killing by orchestrating mTOR signaling. The EMBO journal 42 (5) (2023)
Julia Boshuizen, David W Vredevoogd, Oscar Krijgsman, Maarten A Ligtenberg, Stephanie Blankenstein, Beaunelle de Bruijn, Dennie T Frederick, Juliana C N Kenski, Mara Parren, Marieke Brüggemann, Max F Madu, Elisa A Rozeman, Ji-Ying Song, Hugo Mark Horlings, Christian U Blank, Alexander C J van Akkooi, Keith T Flaherty, Genevieve Marie Boland, Daniel S Peeper
Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance. Nature communications 14 (1) (2023)
Chun-Pu Lin, Joleen J H Traets, David W Vredevoogd, Nils L Visser, Daniel S Peeper
TSC2 regulates tumor susceptibility to TRAIL-mediated T-cell killing by orchestrating mTOR signaling. The EMBO journal (2023)
Julia Boshuizen, David W Vredevoogd, Oscar Krijgsman, Maarten A Ligtenberg, Stephanie Blankenstein, Beaunelle de Bruijn, Dennie T Frederick, Juliana C N Kenski, Mara Parren, Marieke Brüggemann, Max F Madu, Elisa A Rozeman, Ji-Ying Song, Hugo Mark Horlings, Christian U Blank, Alexander C J van Akkooi, Keith T Flaherty, Genevieve Marie Boland, Daniel S Peeper
Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance. Nature communications 14 (1) (2023)
Chun-Pu Lin, Joleen J H Traets, David W Vredevoogd, Nils L Visser, Daniel S Peeper
TSC2 regulates tumor susceptibility to TRAIL-mediated T-cell killing by orchestrating mTOR signaling. The EMBO journal 42 (5) (2023)
Chun-Pu Lin, Joleen J H Traets, David W Vredevoogd, Nils L Visser, Daniel S Peeper
TSC2 regulates tumor susceptibility to TRAIL-mediated T-cell killing by orchestrating mTOR signaling. The EMBO journal 42 (5) (2023)
Chun-Pu Lin, Joleen J H Traets, David W Vredevoogd, Nils L Visser, Daniel S Peeper
TSC2 regulates tumor susceptibility to TRAIL-mediated T-cell killing by orchestrating mTOR signaling. The EMBO journal 42 (5) (2023)
Chun-Pu Lin, Joleen J H Traets, David W Vredevoogd, Nils L Visser, Daniel S Peeper
TSC2 regulates tumor susceptibility to TRAIL-mediated T-cell killing by orchestrating mTOR signaling. The EMBO journal 42 (5) (2023)
Georgi Apriamashvili, David W Vredevoogd, Oscar Krijgsman, Onno B Bleijerveld, Maarten A Ligtenberg, Beaunelle de Bruijn, Julia Boshuizen, Joleen J H Traets, Daniela D'Empaire Altimari, Alex van Vliet, Chun-Pu Lin, Nils L Visser, James D Londino, Rebekah Sanchez-Hodge, Leah E Oswalt, Selin Altinok, Jonathan C Schisler, Maarten Altelaar, Daniel S Peeper
Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling. Nature communications 13 (1) (2022)
Oscar Krijgsman, Kristel Kemper, Julia Boshuizen, David W Vredevoogd, Elisa A Rozeman, Sofia Ibanez Molero, Beaunelle de Bruijn, Paulien Cornelissen-Steijger, Aida Shahrabi, Martin Del Castillo Velasco-Herrera, Ji-Ying Song, Maarten A Ligtenberg, Roelof J C Kluin, Thomas Kuilman, Petra Ross-MacDonald, John B A G Haanen, David J Adams, Christian U Blank, Daniel S Peeper
Predictive Immune-Checkpoint Blockade Classifiers Identify Tumors Responding to Inhibition of PD-1 and/or CTLA-4. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Julia Boshuizen, David W Vredevoogd, Oscar Krijgsman, Maarten A Ligtenberg, Stephanie Blankenstein, Beaunelle de Bruijn, Dennie T Frederick, Juliana C N Kenski, Mara Parren, Marieke Brüggemann, Max F Madu, Elisa A Rozeman, Ji-Ying Song, Hugo Mark Horlings, Christian U Blank, Alexander C J van Akkooi, Keith T Flaherty, Genevieve Marie Boland, Daniel S Peeper
Reversal of pre-existing NGFR-driven tumor and immune therapy resistance. Nature communications 11 (1) (2020)
Julia Boshuizen, Louise A Koopman, Oscar Krijgsman, Aida Shahrabi, Elke Gresnigt- van den Heuvel, Maarten A Ligtenberg, David W Vredevoogd, Kristel Kemper, Thomas Kuilman, Ji-Ying Song, Nora Pencheva, Jens Thing Mortensen, Marnix Geukes Foppen, Elisa A Rozeman, Christian U Blank, Maarten L Janmaat, David Satijn, Esther C W Breij, Daniel S Peeper, Paul W H I Parren
Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors. Nature medicine 24 (2) (2018)

David W Vredevoogd.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David W Vredevoogd